Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00323076 : Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
PhasePhase 1/Phase 2
AgesMin: 16 Years Max: N/A
Eligibility
Inclusion Criteria:

- Male or female greater than or equal to 16 years of age.

- If female of child-bearing potential and outside of the window of 10 days since the
first day of the last menstrual period, a negative pregnancy test is required.

- Patients with known primary or suspected metastatic squamous cell carcinoma of the
head and neck, non-small cell or small cell carcinoma of the lung, lymphoma, GBM
(greater than or equal to 3 glioma), neuroendocrine tumours, or renal cell carcinoma
with at least one lesion >1 cm in diameter.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00323076      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740